Silencing of TICRR and PPIF led to enhance the expression of epithelial marker E-cadherin and decrease the mesenchymal marker N-cadherin and metastasis associated genes MMP9 as well as proliferation-related marker CCND1, suggesting their involvement in the progression of endometrial cancer (Figure 6E). This evidence concerns the gene CDH2 and endometrial cancer.